We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DENTSPLY Sirona Set to Acquire MIS Implants for $375M
Read MoreHide Full Article
DENTSPLY Sirona Inc. (XRAY - Free Report) is set to acquire Israel-based MIS Implants Technologies for $375 million in cash. The transaction is expected to be accretive to adjusted earnings within the first twelve months of the deal closure.
MIS Implants Technologies is a northern Israel (Savion)-based dental implant manufacturer that has a strong customer base across 65 countries, with annual sales of approximately $80 million.
According to data available from Markets & Markets, the global dental implants market is estimated to grow at a CAGR of 7.2% for the forecasted period of 2015-2020. We believe that the latest acquisition will help DENTSPLY to grab significant market share in the long run.
Merger and Acquisition activities have been a key growth driver for DENTSPLY for long. The recently completed merger with Sirona was a key positive for the company. The combined entity will benefit from revenue and cost synergies in 2016 and beyond.
Also, the emerging markets provide significant opportunities for the combined company as these areas are vastly untapped with low dental products penetration.
However, integration will be a risk in the near term. Additionally, higher capital expenditure on product development coupled with persistent decline in sales is expected to put margins under pressure.
Zacks Rank & Key Picks
DENTSPLY has a Zacks Rank #3(Hold).
Better-ranked stocks in the medical space are Halyard health , Bard C R Inc. and Conmed Corp (CNMD - Free Report) . While Halyard health holds a Zacks Rank #1 (Strong Buy), both Bard C R and Conmed Corp carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
DENTSPLY Sirona Set to Acquire MIS Implants for $375M
DENTSPLY Sirona Inc. (XRAY - Free Report) is set to acquire Israel-based MIS Implants Technologies for $375 million in cash. The transaction is expected to be accretive to adjusted earnings within the first twelve months of the deal closure.
MIS Implants Technologies is a northern Israel (Savion)-based dental implant manufacturer that has a strong customer base across 65 countries, with annual sales of approximately $80 million.
According to data available from Markets & Markets, the global dental implants market is estimated to grow at a CAGR of 7.2% for the forecasted period of 2015-2020. We believe that the latest acquisition will help DENTSPLY to grab significant market share in the long run.
Merger and Acquisition activities have been a key growth driver for DENTSPLY for long. The recently completed merger with Sirona was a key positive for the company. The combined entity will benefit from revenue and cost synergies in 2016 and beyond.
DENTSPLY SIRONA Revenue (TTM)
DENTSPLY SIRONA Revenue (TTM) | DENTSPLY SIRONA Quote
Also, the emerging markets provide significant opportunities for the combined company as these areas are vastly untapped with low dental products penetration.
However, integration will be a risk in the near term. Additionally, higher capital expenditure on product development coupled with persistent decline in sales is expected to put margins under pressure.
Zacks Rank & Key Picks
DENTSPLY has a Zacks Rank #3(Hold).
Better-ranked stocks in the medical space are Halyard health , Bard C R Inc. and Conmed Corp (CNMD - Free Report) . While Halyard health holds a Zacks Rank #1 (Strong Buy), both Bard C R and Conmed Corp carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>